New
Prognica
The AI engine Fit Assessment
BetaPrognica Labs is dedicated to advancing women's health through AI-driven technologies for early detection and diagnosis of breast cancer, including enhancements to mammography.
Blurb
Prognica is building smart screening solution for early detection of breast cancer using artificial intelligence and machine learning.
HQ Location
United Arab Emirates
Founded
2019
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Pre-Seed, July 16, 2019
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Artificial Intelligence in Women's Health Care
Operator of an AI-powered health-tech company intended to improve clinical outcomes. The company utilizes machine learning and computer vision to accelerate the discovery of breakthrough advancements in the fight against cancer, analyze medical images and generate information and data to help predict and diagnose cancer, enabling healthcare professionals to make early detection and diagnosis of breast cancer, more accurate, accessible and affordable.